{"database": "press", "table": "releases", "rows": [["https://schweikert.house.gov/2024/06/27/house-committee-on-ways-means-passes-schweikert-legislation-requiring-the-reimbursement-of-ai-powered-wearables/", "House Committee on Ways & Means Passes Schweikert\u00a0Legislation Requiring the Reimbursement of AI-Powered Wearables", "2024-06-27", "2024", "2024-06", "Republican", "House", "AZ", "David Schweikert", "S001183", "schweikert.house.gov", "schweikert", "https://schweikert.house.gov/category/congress_press_release/", "scraper", "WASHINGTON, D.C. \u2014 Today, the House Ways and Means Committee passed H.R. 8832, the Maintaining Innovation and Safe Technology Act, legislation that would direct the Department of Health and Human Services (HHS) to establish reimbursement guidance for remote monitoring devices that use AI to treat patients.\n\nIn a paper prepared by the National Bureau of Economic Research, researchers estimated that the further implementation of artificial intelligence into our health care system could produce savings from 5% to 10% of spending, which equates to around $200 billion to $360 billion annually in 2019 dollars. Forbes has also estimated that promoting the use of health-monitoring wearable devices could result $200 billion in cost-savings over the next 25 years.\n\n\u201cMy fascination with AI integration has been ever-present. This legislation embraces the morality that is tied to implementing innovation further in our health care system,\u201d said Rep. Schweikert. \u201cAutomating the organization and collection of patient information has proven to ease burdens off of physicians, detect health irregularities quicker, and provide hundreds of million dollars in savings each year. The potential for wearable devices to save American lives and American dollars is expanding, and it\u2019s time for coverage to reflect that.\u201d\n\n\u201cFederal bureaucracy shouldn\u2019t be standing in the way of tools which can provide enhanced outcomes to patients. Agencies and providers all working together to leverage all available tools on behalf of patients, including AI, will yield higher quality of care and help lower costs in the health care system. Congressman Schweikert\u2019s legislation would require Medicare to review and report on their existing authorities to cover AI-assisted health care so innovators and Congress can chart a course for the future of health care in America.\u201d said Ways and Means Committee Chairman Jason Smith (MO-08).\n\n\u201cTechnology has tremendously improved our lives in so many ways, and with breakthroughs in Artificial Intelligence, it\u2019s time we apply that to our medical care,\u201d said Rep. Hern. \u201cSafe AI will provide important benefits to patients while unlocking untold potential in new technologies. I\u2019m proud to introduce this legislation in the House to ensure Americans have access to cutting-edge care that is both safe and innovative.\u201d\n\nBackground on the Maintaining Innovation and Safe Technology Act:\n\nCurrently, the FDA has approved over 882 devices that use AI or machine learning to treat, diagnosis, and care for patients.\n\nNew FDA-approved bionic pancreas uses AI to help type 1 diabetes patients\n\nAnnalise.ai Receives FDA Clearance and Breakthrough Device Designation\n\nAI-developed blood test can predict Parkinson\u2019s seven years early\n\nApple Watch\u2019s afib-tracking app certified by FDA for use in clinical studies\n\nNew FDA-approved bionic pancreas uses AI to help type 1 diabetes patients\n\nAnnalise.ai Receives FDA Clearance and Breakthrough Device Designation\n\nAI-developed blood test can predict Parkinson\u2019s seven years early\n\nApple Watch\u2019s afib-tracking app certified by FDA for use in clinical studies\n\nNew FDA-approved bionic pancreas uses AI to help type 1 diabetes patients\n\nAnnalise.ai Receives FDA Clearance and Breakthrough Device Designation\n\nAI-developed blood test can predict Parkinson\u2019s seven years early\n\nApple Watch\u2019s afib-tracking app certified by FDA for use in clinical studies\n\nUsing 2019 Census Bureau data, spending on medical and in-vitro diagnostics totaled $199.1 billion, or 5.2 % of all health care spending.\n\nIn 2019, Medicare expanded coverage for remote patient monitoring (RPM).\n\nFrom February 2020 to September 2021, general RPM use per month increased from 91 to 594 claims per 100,000 enrollees\u2013 an increase of 555%.\n\nAI has streamlined many processes for physicians, patients and hospitals, like early diagnostics/detection, analyzation of comprehensive data sets, and medication management.\n\nThe full text of the bill can be found here.\n\n###Congressman David Schweikert serves on the Ways and Means Committee and is the current Chairman of the Oversight Subcommittee. He is also the Vice Chairman on the bicameral Joint Economic Committee, chairs the Congressional Valley Fever Task Force, and is the Republican Co-Chair of the Blockchain Caucus, Telehealth Caucus, Singapore Caucus, and the Caucus on Access to Capital and Credit.\n\nBack to News", 1, "2026-03-30T01:40:41Z", "2026-04-07T21:11:47Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://schweikert.house.gov/2024/06/27/house-committee-on-ways-means-passes-schweikert-legislation-requiring-the-reimbursement-of-ai-powered-wearables/"], "units": {}, "query_ms": 1.694028964266181, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}